AngioDynamics Inc Total Assets
AngioDynamics Inc total assets. Based on the latest financial reports, AngioDynamics Inc (ANGO) holds total assets worth $267.16 Million USD as of May 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see ANGO market cap for the company's overall valuation and market capitalisation.
Total Assets of AngioDynamics Inc (2002–2026)
Total assets of AngioDynamics Inc from 2002 to 2026. This chart illustrates how AngioDynamics Inc's total assets have evolved over time, based on quarterly financial data. See AngioDynamics Inc (ANGO) share price today for real-time trading data and today's change.
AngioDynamics Inc - Asset Composition Analysis
AngioDynamics Inc Total Assets Breakdown (May 2026)
AngioDynamics Inc total assets breakdown as of May 2026. AngioDynamics Inc's total assets of $267.16 Million consist of 61.2% current assets and 38.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 20.2% |
| Accounts Receivable | $48.33 Million | 18.1% |
| Inventory | $52.44 Million | 19.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $67.21 Million | 25.2% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2002–2026)
This chart illustrates how AngioDynamics Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore AngioDynamics Inc short-term liquidity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: AngioDynamics Inc's current assets represent 61.2% of total assets in 2026, a decrease from 76.9% in 2002.
- Cash Position: Cash and equivalents constituted 20.2% of total assets in 2026, up from 7.4% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 25.0% of total assets, an increase from 5.0% in 2002.
- Asset Diversification: The largest asset category is intangible assets at 25.2% of total assets.
AngioDynamics Inc Competitors by Total Assets
Key competitors of AngioDynamics Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
HOYA CORP. ADR/ 1 O.N.
F:HYB0
|
Germany | €1.23 Trillion |
|
Autek China Inc
SHE:300595
|
China | CN¥6.40 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Mingyue Optical Lens Co.Ltd.
SHE:301101
|
China | CN¥2.09 Billion |
|
Medeon Biodesign
TWO:6499
|
Taiwan | NT$1.55 Billion |
|
SDI Ltd
AU:SDI
|
Australia | AU$135.84 Million |
|
Nextgen
TA:NXGN
|
Israel | ILA1.48 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.39 Billion |
AngioDynamics Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.19 | 2.21 | 2.52 |
| Quick Ratio | 1.49 | 1.40 | 1.57 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $88.68 Million | $92.13 Million | $79.22 Million |
AngioDynamics Inc - Advanced Valuation Insights
This section examines the relationship between AngioDynamics Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.70 |
| Latest Market Cap to Assets Ratio | 1.85 |
| Asset Growth Rate (YoY) | -4.6% |
| Total Assets | $267.16 Million |
| Market Capitalization | $495.58 Million USD |
Valuation Analysis
Above Book Valuation: The market values AngioDynamics Inc's assets above their book value (1.85x), reflecting positive investor sentiment about the company's future prospects.
Slight Asset Contraction: AngioDynamics Inc's assets decreased by 4.6% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for AngioDynamics Inc (2002–2026)
The table below shows the annual total assets of AngioDynamics Inc from 2002 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-05-31 | $267.16 Million | -4.63% |
| 2025-05-31 | $280.14 Million | -11.81% |
| 2024-05-31 | $317.67 Million | -40.36% |
| 2023-05-31 | $532.64 Million | -3.64% |
| 2022-05-31 | $552.75 Million | -1.55% |
| 2021-05-31 | $561.44 Million | -5.72% |
| 2020-05-31 | $595.51 Million | -28.80% |
| 2019-05-31 | $836.44 Million | +18.56% |
| 2018-05-31 | $705.47 Million | -0.35% |
| 2017-05-31 | $707.96 Million | -2.76% |
| 2016-05-31 | $728.06 Million | -5.89% |
| 2015-05-31 | $773.62 Million | -3.32% |
| 2014-05-31 | $800.16 Million | +1.04% |
| 2013-05-31 | $791.88 Million | +9.21% |
| 2012-05-31 | $725.08 Million | +65.71% |
| 2011-05-31 | $437.55 Million | +3.21% |
| 2010-05-31 | $423.93 Million | +3.72% |
| 2009-05-31 | $408.70 Million | -0.01% |
| 2008-05-31 | $408.75 Million | +6.64% |
| 2007-05-31 | $383.28 Million | +179.77% |
| 2006-05-31 | $137.00 Million | +129.59% |
| 2005-05-31 | $59.67 Million | +20.00% |
| 2004-05-31 | $49.73 Million | +83.79% |
| 2003-05-31 | $27.06 Million | +31.04% |
| 2002-05-31 | $20.65 Million | -- |
About AngioDynamics Inc
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vesse… Read more